Molecular Imaging: Page 36

Whole-body MRI on par with PET/CT for myeloma

By AuntMinnieEurope.com staff writers

U.K. researchers found that whole-body MRI was more sensitive for assessing bone lesions in multiple myeloma than F-18 FDG-PET/CT but did not result in a statistically significant difference in patient management, according to results published on 19 January in the European Journal of Nuclear Medicine and Molecular Imaging.

January 21, 2021

Danish hospital images 1st patient with PET water device

By AuntMinnieEurope.com staff writers

Aarhus University Hospital in Denmark imaged its first patients with MedTrace Pharma's device for oxygen-15 PET imaging to measure myocardial blood flow.

January 17, 2021

Blue Earth buys therapeutic rights to rhPSMA technology

By AuntMinnieEurope.com staff writers

Bracco molecular imaging subsidiary Blue Earth Diagnostics has acquired exclusive, worldwide rights to therapeutic applications of radiohybrid prostate-specific membrane antigen (rhPSMA) technology developed by German radiopharmaceutical firm Scintomics and the Technical University of Munich.

January 4, 2021

What impact will Brexit deal have on radiology?

By Steve Holloway

The protracted political, economic, and regulatory game of chess played by London and Brussels finally came to an end when the U.K. and European Union's Trade and Cooperation Agreement was signed on 24 December. Market columnist Steve Holloway assesses the implications of the Brexit deal.

January 4, 2021

AuntMinnieEurope.com Molecular Insider

By Philip Ward

December 14, 2020

PET/CT can boost outcome in hyperparathyroidism cases

By Philip Ward

Using a combination of several modalities, including PET/CT, to achieve an accurate diagnosis is vital to reduce the likelihood of surgical failure and the risk of complications in cases of persistent or recurrent primary hyperparathyroidism, researchers from a leading London facility have reported.

December 14, 2020

Nuclear medicine copes with upheaval in pandemic

By Leo Cendrowicz

At one point this year, it looked like Europe's entire nuclear medicine sector would have to be put on hold, said Antonis Kalemis, PhD, president of Nuclear Medicine Europe. When COVID-19 began spreading rapidly, industry felt huge anxiety as the lockdown measures escalated, but it has pulled together and survived.

December 14, 2020

Euro health bodies announce 5-year strategy

By AuntMinnieEurope.com staff writers

The European Medicines Agency and the Heads of Medicines Agencies have released their five-year strategy, which includes prioritizing digital technologies and more.

December 8, 2020

ITM receives drug master file for gallium generator

By AuntMinnieEurope.com staff writers

German radiopharmaceutical firm ITM Isotopen Technologien has been granted a drug master file by the U.S. Food and Drug Administration for its GeGant germanium-68/gallium-68 generator.

December 7, 2020

Total-body PET can prove a game changer

By Frances Rylands-Monk

Higher image quality, lower patient and staff radiation exposure, simultaneous multiorgan imaging, and expanded range for optimal dose imaging are among the significant advantages that total-body PET can bring to the clinical setting, according to a leading hybrid imaging expert.

November 24, 2020

Emer Cooke becomes first female head of EMA

By AuntMinnieEurope.com staff writers

Emer Cooke began her role as executive director of the European Medicines Agency (EMA) on 16 November.

November 16, 2020

Isotopia partners with Y-mAbs on radioisotope

By AuntMinnieEurope.com staff writers

Isotopia Molecular Imaging is collaborating with biopharmaceutical company Y-mAbs Therapeutics for the supply of the medical radioisotope no-carrier-added lutetium-177.

November 8, 2020

Previous Page

Page 36 of 121

Next Page